{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:38:55Z","timestamp":1792618735908,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijgc.2026.105613","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:44:50Z","timestamp":1789688690000},"page":"105613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frailty assessment in ovarian cancer: a systematic review of measurement definitions, methods, and clinical implications"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-2173","authenticated-orcid":false,"given":"Alicia","family":"Castelo-Loureiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Alqaisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8316-7759","authenticated-orcid":false,"given":"Rouhi","family":"Fazelzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-2729","authenticated-orcid":false,"given":"Myriam","family":"Rodr\u00edguez-Couso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-7425","authenticated-orcid":false,"given":"Mariana M.","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Soto-Perez-de-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lheureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit M.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-9762","authenticated-orcid":false,"given":"Ainhoa","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib1","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10206","key":"10.1016\/j.ijgc.2026.105613_bib2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijgc.2026.105613_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Sci World J"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"issue":"26","key":"10.1016\/j.ijgc.2026.105613_bib5","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1016\/j.ijgc.2026.105613_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103657","article-title":"Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO\/SIOG Cancer in the Elderly Working Group","volume":"9","author":"Loh","year":"2024","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.105613_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/ijgc-2020-001288","article-title":"Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events","volume":"30","author":"Madariaga","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.ijgc.2026.105613_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102117","article-title":"Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches","volume":"35","author":"Ciliberti","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.105613_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2026.105613_bib11","series-title":"JBI Manual for Evidence Synthesis","year":"2024"},{"key":"10.1016\/j.ijgc.2026.105613_bib12","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle\u2013Ottawa scale for assessing the quality of non-randomised studies in meta-analyses. Ottawa Hospital Research Institute. Accessed 1st May, 2026. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"6","key":"10.1016\/j.ijgc.2026.105613_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ijgc-2021-003190","article-title":"Prospective non-interventional BELOVA\/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group","volume":"32","author":"Vergote","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2026.105613_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1159\/000520328","article-title":"G-8 geriatric screening tool independently predicts progression-free survival in older ovarian cancer patients irrespective of maximal surgical effort: results of a retrospective cohort study","volume":"68","author":"Anic","year":"2022","journal-title":"Gerontology"},{"issue":"6","key":"10.1016\/j.ijgc.2026.105613_bib15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00404-022-06850-4","article-title":"Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study","volume":"307","author":"Anic","year":"2023","journal-title":"Arch Gynecol Obstet"},{"issue":"39","key":"10.1016\/j.ijgc.2026.105613_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012298","article-title":"Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?","volume":"97","author":"Ferrero","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygyno.2019.03.249","article-title":"Determinants of health-related quality of life in elderly ovarian cancer patients: the role of frailty and dependence","volume":"153","author":"de Arruda","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2018.11.031","article-title":"Chemotherapy in older adult gynecologic oncology patients: can a phenotypic frailty score predict tolerance?","volume":"152","author":"Hay","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2019.04.683","article-title":"Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center","volume":"154","author":"Filippova","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ygyno.2021.03.016","article-title":"Frailty based on the Memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer","volume":"161","author":"Filippova","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s13193-022-01499-6","article-title":"The frailty based on the Memorial Sloan Kettering frailty index for prediction of surgical outcome in advance epithelial ovarian cancer-experience of a Single Center in Mexico","volume":"13","author":"Aguilar-Frasco","year":"2022","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2021.05.013","article-title":"Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"162","author":"Chambers","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2020.08.022","article-title":"Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer","volume":"161","author":"Di Donato","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.105613_bib24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/IGC.0000000000001097","article-title":"Ovarian cancer in elderly patients: patterns of care and treatment outcomes according to age and modified frailty index","volume":"27","author":"Ferrero","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/ijgc-2022-003603","article-title":"Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer","volume":"33","author":"Ramos","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2019.11.008","article-title":"Modified frailty index is predictive of wound complications in obese patients undergoing gynecologic surgery via a midline vertical incision","volume":"157","author":"Mullen","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2022.05.009","article-title":"Frailty repels the knife: the impact of frailty index on surgical intervention and outcomes","volume":"166","author":"Handley","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.105613_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1052628","article-title":"Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: a multicenter retrospective cohort study","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ygyno.2020.05.046","article-title":"Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer","volume":"158","author":"Narasimhulu","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2018.12.025","article-title":"Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery","volume":"153","author":"Yao","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00404-020-05807-9","article-title":"Impact of frailty on the management of patients with gynecological cancer aged 80 years and older","volume":"303","author":"Reiser","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijgc.2026.105613_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2023.11.031","article-title":"Relationship between frailty and nutrition: refining predictors of mortality after primary cytoreductive surgery for ovarian cancer","volume":"180","author":"Chauhan","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ygyno.2021.02.027","article-title":"A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy","volume":"161","author":"Mullen","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2020.08.024","article-title":"Effect of frailty on postoperative readmissions and cost of care for ovarian cancer","volume":"159","author":"Sia","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2026.105613_bib35","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/annonc\/mdt360","article-title":"Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial","volume":"24","author":"Falandry","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.105613_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2016.03.018","article-title":"Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: results of a pooled analysis of three GINECO phase II trials","volume":"143","author":"Tinquaut","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib37","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/S2666-7568(22)00002-2","article-title":"Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study","volume":"3","author":"Falandry","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"6","key":"10.1016\/j.ijgc.2026.105613_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jamaoncol.2021.0696","article-title":"Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian cancer: a GINECO\/GCIG randomized clinical trial","volume":"7","author":"Falandry","year":"2021","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2018.05.022","article-title":"Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: an NRG oncology group\/gynecologic oncology group study","volume":"150","author":"Ahmed","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jjco\/hyz178","article-title":"Comprehensive geriatric assessment is correlated to overall survival among gynaecologic oncology patients","volume":"50","author":"Michaan","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2026.105613_bib41","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/annonc\/mdi368","article-title":"Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study","volume":"16","author":"Freyer","year":"2005","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdl400","article-title":"Carboplatin\/cyclophosphamide or carboplatin\/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d\u2019Investigateurs Nationaux pour l\u2019Etude des Cancers Ovariens","volume":"18","author":"Tr\u00e9dan","year":"2007","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.105613_bib43","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/IGC.0b013e318299438a","article-title":"CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer","volume":"23","author":"Won","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105613_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jgo.2014.03.004","article-title":"Pre- and intra-operative variables associated with surgical complications in elderly patients with gynecologic cancer: the clinical value of comprehensive geriatric assessment","volume":"5","author":"Suh","year":"2014","journal-title":"J Geriatr Oncol"},{"issue":"10314","key":"10.1016\/j.ijgc.2026.105613_bib45","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijgc.2026.105613_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2026.105613_bib47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund","year":"2021","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2026.105613_bib48","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","article-title":"Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial","volume":"3","author":"Soo","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"10.1016\/j.ijgc.2026.105613_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2024-005883","article-title":"Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies","volume":"36","author":"Madariaga","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.105613_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2024.02.003","article-title":"High grade adverse event reporting and enrolment in gynecologic oncology clinical trials","volume":"185","author":"Madariaga","year":"2024","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26011448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26011448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:59:29Z","timestamp":1792616369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26011448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S1048891X26011448"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.105613","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty assessment in ovarian cancer: a systematic review of measurement definitions, methods, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.105613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105613"}}